Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperoxia and Hypoxia on FLIO
NCT04094285Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2019
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Changes in FLIO induced by hyperoxia at 15 minutes. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT04094285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094285.